Department of Health and Social Care (DHSC) has issued a medicine supply notification for Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials MSN/2024/059 Tier 2 – medium impact Date of issue: 23rd May 2024 There will be intermittent supplies of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebules for the foreseeable future. Unlicensed supplies of salbutamol 2.5mg
Read moreThe Department of Health and Social Care (DHSC) has today (24/05/2024) confirmed the following initial list of price concessions for May 2024. This announcement comes late in the month and follows the decision by DHSC, under the direction of Ministers, to impose changes to concessions pricing from April 2024 to try to manage purchase margins. DHSC
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Nortriptyline 10mg/5ml and 25mg/5ml oral solution sugar-free MSN/2024/061 Tier 2 – medium impact Date of issue: 23rd May 2024 Nortriptyline 10mg/5ml oral solution sugar-free has been discontinued; all supplies have now been exhausted Nortriptyline 25mg/5ml oral solution sugar-free will be discontinued
Read moreClass 4 Medicines Defect Information: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS (Fresenius Kabi Limited) Drug alert number: EL (24)A/17 Date issued: 22 May 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Sodium Chloride 0.9% Intravenous Infusion BP Freeflex and Freeflex PLUS
Read moreIn response to a significant ongoing disruption to the supply of Clarithromycin 125mg/5ml and 250mg/5ml oral suspension, Ministers have authorised the Department of Health and Social Care (DHSC) to reactivate two Serious Shortage Protocols (SSPs). Effective 22 May 2024, SSP053 and SSP054 provides for the following: SSP053 – for every 5ml of Clarithromycin 125mg/5ml oral suspension,
Read moreCommunity Pharmacy England today briefed Peers on the severe challenges facing community pharmacies, including the findings of the 2024 Pressures Survey. In a wide-ranging discussion, Peers were taken through findings on medicine supply issues, funding pressures, and pharmacy workforce shortages, as well as hearing about Pharmacy First. Chaired by former Pharmacy Minister Lord Hunt of
Read moreFollowing representations made by Community Pharmacy England, the Department of Health and Social Care (DHSC) has agreed that prescriptions requesting Azathioprine 50mg/5ml oral suspension (Special Order) submitted as dispensed in February and March 2024 will be reimbursed based on the product endorsed. Prescriptions submitted as dispensed in February or March 2024 will be reimbursed as
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Humulin® S (insulin soluble human) 100units/ml solution for injection 10ml vials. This MSN is the second of two covering supply issues with insulin vials. The first MSN (MSN/2024/053) issued on 09/05/24 covered Humalog® vials. This MSN (MSN/2024/057) covers Humulin® S (insulin
Read moreClass 4 Medicines Defect Information: Trazodone hydrochloride 50mg/5ml oral solution (Cygnus Pharma Ltd) Drug alert number: EL (24)A/16 Date issued: 20 May 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Trazodone hydrochloride 50mg/5ml oral solution (Cygnus Pharma Ltd) Company name: Cygnus Pharma Ltd Product name:
Read morePharmacy owners and their teams can now access guidance about the upcoming national Pharmacy Advice Audit, including full details of how to take part between 3rd and 16th June 2024. As announced earlier this month, Community Pharmacy England’s audit will help demonstrate how pharmacies are supporting their communities every day and assist in gathering critical evidence for
Read more
